首页> 外国专利> ORAL PHARMACEUTICAL COMPOSITION DIURETIC AND ACE INHIBITOR IN MICRONIZED FORM, MEDICINAL PRODUCT AND ITS APPLICATION

ORAL PHARMACEUTICAL COMPOSITION DIURETIC AND ACE INHIBITOR IN MICRONIZED FORM, MEDICINAL PRODUCT AND ITS APPLICATION

机译:微粉化形式,药物产品的口腔药物组合物利尿剂和ACE抑制剂及其应用

摘要

1. An oral pharmaceutical composition containing a combination of a diuretic and an ACE inhibitor, characterized in that said active substances are in micronized form. Oral pharmaceutical composition according to claim 1, characterized in that the micronized form of the active components has an average particle size of less than 50 microns. Oral pharmaceutical composition according to claim 1, characterized in that the micronized form of the active components has a specific surface area of at least 20 · 10 cm / mg. Oral pharmaceutical composition according to any one of claims 1 to 3, characterized in that the ACE inhibitor is selected from the group consisting of ramipril, enalapril, perindopril, lisinopril, fosinopril. Oral pharmaceutical composition according to any one of claims 1 to 3, characterized in that the diuretic is selected from the group consisting of indapamide, chlortiazide, methiclotiazide, bendroflumethiazide, chlortalidone, metolazone and hydrochlorothiazide. 6. Antihypertensive drug containing an oral pharmaceutical composition according to any one of claims 1 to 3, characterized in that it contains ramipril and indapamide and, optionally, pharmaceutically acceptable excipients, mg: 7. The antihypertensive drug containing the oral pharmaceutical composition according to claim 6, characterized in that it contains ramipril and indapamide as active substances, and lactose monohydrate, silicon dioxide colloidal (aerosil), calcium stearate as auxiliary substances. An antihypertensive drug containing an oral pharmaceutical composition according to any one of claims 1-
机译:1.一种包含利尿剂和ACE抑制剂的组合的口服药物组合物,其特征在于所述活性物质为微粉化形式。 2.根据权利要求1的口服药物组合物,其特征在于活性成分的微粉化形式具有小于50微米的平均粒度。 2.根据权利要求1的口服药物组合物,其特征在于活性成分的微粉化形式的比表面积至少为20·10cm / mg。 4.根据权利要求1至3中任一项所述的口服药物组合物,其特征在于,所述ACE抑制剂选自雷米普利,依那普利,培哚普利,赖诺普利,福辛普利。 4.根据权利要求1至3中任一项所述的口服药物组合物,其特征在于,所述利尿剂选自吲达帕胺,氯噻嗪,甲环噻嗪,苯并氟甲酰肼,氯他啶酮,甲硝唑酮和氢氯噻嗪。 6.包含根据权利要求1-3中任一项的口服药物组合物的降压药,其特征在于它包含雷米普利和吲达帕胺以及任选的药学上可接受的赋形剂,mg:7.包含权利要求6的口服药物组合物的降压药。 6,其特征在于它含有雷米普利和吲达帕胺作为活性物质,以及乳糖一水合物,二氧化硅胶体(aerosil),硬脂酸钙作为辅助物质。 7.一种降压药,其包含根据权利要求1至8中任一项所述的口服药物组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号